Health Technology Assessment (HTA) is the systematic evaluation of the properties and effects of a health technology, addressing the direct and intended effects of this technology, as well as its indirect and unintended consequences. It is aimed mainly at informing decision making regarding health technologies.
The HSR team performs HTAs to support decision-making on clinical service planning, programme development as well as the Medical Device Oversight Committee on the adoption of medical devices and implants at CGH. The team also collaborates on research projects by providing evidence to support implementation, and educates stakeholders in CGH on doing and using HTA.
2014 Clinical Service Planning Support
As part of the Marketplace exercise, the team conducted rapid reviews for nine of 40 proposals submitted to provide evidence-based decision support for senior management. An additional rapid review was then conducted for theOne Step Nucleic Acid Amplification Machine. These reviews strengthened the decision-making process in prioritising programmes.
Health Services Development Programme
The team supported the MOH Health Services Development Programme process by conducting independent assessments of the evidence of each programme and assisting programme directors in establishing evaluation frameworks for clinical programmes. This gave senior management insights that allowed them to determine which programmes would be submitted to MOH for further review.
Medical Device Oversight Committee
The HSR team is represented on the Medical Device Oversight Committee (MDOC) which was formed in November 2014. The committee unifies the various conduits through which medical devices can enter use within CGH. It has stipulated data items to be captured for all new medical devices introduced in the hospital and has developed processes for monitoring utilisation and tracking outcomes from the use of these devices. HSR supports the MDOC by performing rapid reviews for decision-making and the development of process and clinical outcomes to evaluate the performance of the devices.
Visit by MOH Bhutan
From 14 to 15 Apr 2015, CGH hosted a delegation of four program officers from the Ministry of Health Bhutan. After spending a day at MOH Singapore, they spent the next two days at CGH, learning about hospital-based health technology assessment and regulatory licensing of healthcare facilities in Singapore. In addition, they attended a workshop on conducting rapid health technology assessment, co-organised by the HSR team and the Singapore Clinical Research Institute. Ms Deepika Adhikari, Program Officer of the Essential Medicines and Technology Division, delivered a lecture to the public health community entitled “Health Technology Assessment for Happiness: Healthcare in the Kingdom of Bhutan”, which discussed how HTA helped in making evidence-based decisions on allocation of scarce resources in Bhutan. The delegation from Bhutan found their visit fruitful in learning about the Singapore health system and establishing links with their Singapore counterparts.
2 Simei Street 3,
(65) 6788 8833
(65) 6788 0933
Changi General Hospital (CGH)